Eli Lilly and Co
Iran tensions, Palantir earnings, Musk’s SEC settlement and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Tuesday. Yesterday was a busy day for Amazon‘s top brass: CEO Andy Jassy joined CNBC’s “Mad Money,” while executive chairman Jeff Bezos was the honorary co-chair and lead sponsor of last night’s Met Gala. Stock futures are rising this morning after […]
Read More
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight. LifeMD went from seeing […]
Read More
‘Bubble effect’: Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a “bubble effect” as profitability soars, new research suggests. Demand for the likes of Wegovy and Zepbound has driven research and development returns to their highest level in years, but a report published by Deloitte on Monday suggests this is […]
Read More
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary hair thinning and prepared for the worst. But it would take about a year before she began noticing her hair falling out in clumps. Cooper said it was especially shocking because she has always had […]
Read More
Apple earnings, DHS shutdown, ‘Ozempic breath’ and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. My colleagues and I will be covering Berkshire Hathaway‘s annual meeting tomorrow — its first without Warren Buffett as CEO. You can follow along with our special coverage on TV and online. S&P 500 futures are little changed this morning […]
Read More
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed | Reuters The Food and Drug Administration on Thursday proposed excluding the active ingredients in Novo Nordisk and Eli Lilly‘s blockbuster obesity and diabetes medications from the list of drugs that outsourcing facilities can use for compounding […]
Read More
More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]
Read More
Stocks making the biggest moves premarket: Meta, Eli Lilly, Caterpillar, Amazon & more
Check out the companies making the biggest moves in premarket trading: Meta Platforms — The Facebook parent dropped 9% after the company hiked its full-year capital expenditures guidance to a range of $125 billion to $145 billion, raising concern over its AI spending. That forecast overshadowed a better-than-expected Q1 report. Eli Lilly — The Zepbound […]
Read More
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IMF) and World Bank Spring meetings in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past […]
Read More
Inside India newsletter: AI is exposing cracks in India’s growth story as it hits high-paying IT jobs
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India“ — your one-stop destination for stories and developments from the world’s fastest growing large economy. Over the past two decades, India’s IT sector has been driving a consumption boom that has in many ways anchored the India growth story. […]
Read More